This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Kevin Sayer, CEO of Dexcom, sat down with Pharmacy Times® at the 85th Scientific Sessions of the American Diabetes Association (ADA) in Chicago, Illinois, to discuss how continuous glucose monitors (CGMs) offer patients with type 2 diabetes (T2D) a comprehensive "scoreboard" of their health.
Prior to October 2024, the Advisory Committee on Immunization Practices (ACIP) recommended use of a PCV only for all adults aged 65 years and older, including those aged 19 to 64 years with risk conditions for pneumococcal disease.
These pharmacies provide patient-centered enhanced services, such as point of care testing (POCT), to improve patient health outcomes. My Prior Experience I have worked as a pharmacytechnician and now as a pharmacy intern at a chain pharmacy for the past four years in New Jersey and Florida.
Experts emphasized oral semaglutide as a promising alternative to injectable GLP-1 receptor agonists for managing diabetes and cardiovascular risk. The trial demonstrated consistent benefits across diverse populations, including those using SGLT2 inhibitors, with a favorable safety profile.
In an interview with Pharmacy Times ®, Diana Isaacs, PharmD, BCPS, BC-ADM, BCACP, CDCES, FADCES, FCCP, remote monitoring program coordinator and endocrinology clinical pharmacy specialist at the Cleveland Clinic, shares insights about the upcoming American Diabetes Association 85th Scientific Sessions.
2 Vitamin D Immunity Vitamin D is a crucial hormone that supports bone health by facilitating the absorption of calcium and phosphorus, which is obtained mainly from sunlight exposure and food. Vitamin D is an accessible and inexpensive option compared to other drugs used to improve the response to chemotherapy.”
He emphasizes the importance of staying updated on medical advancements through state pharmacy associations, digital health platforms, and engaging with students and residents.
SHOW MORE New research reveals a significant link between type 2 diabetes, obesity, and fatty liver disease. Emerging study findings from investigators at Linköping University discovered that 6 out of 10 individuals with type 2 diabetes (T2D) had fatty liver.
Wick, MBA, RPh, FASCP Key Takeaways Pharmacists can address SDOH by providing patient-centered care, promoting immunizations, and offering point-of-care testing to improve health outcomes. Wick, MBA, RPh, FASCP, is the director of the Office of Pharmacy Professional Development at the University of Connecticut in Storrs.
The dual-target approach of amylin and GLP-1 receptor agonists offers a promising strategy for managing obesity and type 2 diabetes. SHOW MORE CagriSema shows promising weight loss and metabolic benefits in recent trials, offering new hope for obesity and type 2 diabetes management.
In addition, pharmacytechnicians conduct monthly refill adherence calls, and patients have the option for in-clinic assessments if needed. The program begins with a pharmacist-led initial assessment prior to dispensing, followed by a clinical check-in within 3 weeks.
The session, which was entitled “Decoding the Logic: An Overview of Biologics and Biosimilars,” described clinical applications and economic impacts associated with biologics and biosimilars over the last 10 to 15 years, as well as outlined what skills effectively contribute to their management and understanding.
As health care rapidly changes, the role of pharmacists and pharmacytechnicians will have to evolve alongside it, said Donald Klepser, PhD, MBA, professor and interim dean at the University of Nebraska Medical Center.
For example, CPAs are especially impactful in managing chronic conditions such as diabetes, heart failure, and rheumatoid arthritis, where pharmacist intervention has been shown to improve outcomes and reduce hospitalizations. Creating disease-specific competency assessments also ensures alignment with evolving standards of care.
Newsletter Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights. Related Videos Related Content Advertisement April 22nd 2025 Where Is PharmacyTechnician CE in Oncology? Subscribe Now!
4 Nononcology applications are growing, however, particularly for conditions such as osteoarthritis, type 1 diabetes, and Parkinson disease. The most targeted cancers include acute myeloid leukemia, liver cancer, and pancreatic cancer.
Pharmacy Times : As immunotherapies expand into the solid tumor space, clinicians are reporting cases of ICANS and CRS. Have you observed these immune-related toxicities in your practice, and if so, how are they being managed? All patients should have immunotherapy first. It was approved last year.
Results Data will include toxicity management in the OP setting (eg, rates and grades of CRS/immune effector cell–associated neurotoxicity syndrome, deferred admissions, etc), an algorithm for appropriately selecting patients for OP administration, and a specific OP SUD treatment protocol.
Our certified pharmacytechnicians contact the patient prior to them running out of meds to confirm that they A, need the medication, and B, confirm a specific delivery date that works for them. A gold standard for specialty pharmacies is 24/7 access to a pharmacist for clinical and non-clinical inquiries.
2,3 Steqeyma, which was formerly known as CT-P43, is a human IL-12 and IL-23 antagonist indicated for multiple immune-mediated diseases. Lifestyle modifications that may also relieve symptoms include exercise, applying heat or cold to the affected areas, and occupational and/or physical therapy.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content